biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by ronrydellon Jul 17, 2020 3:25pm

219 Views

Post# 31282877

Disappointing yet grateful that....

.......that we haven’t had an expected bump but neither presentor had much passion or delivery skills....but grantful that we haven’t dropped much...never want to visit those lows again from the last few months...what a total bummer...Deborah needs to pull up another licensing agreement, especially in our space....hope it happens before the end of summer...love to see $.50 Canadian.

Bullboard Posts

Calibre discovers significant gold in Newfoundland